{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:43:27Z","timestamp":1780983807260,"version":"3.54.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Mesenchymal stem cells (MSCs) have attracted great interest in the field of kidney transplantation due to their immunomodulatory and reparative properties. In registered clinical trials, MSCs have been used before, at the time of, or early after transplantation and have been reported to be well-tolerated with no serious safety concerns. No results are available on the use of MSCs in the late post-transplant period. Here, we present a case report of a severe systemic complication mimicking capillary leak syndrome with ultimate kidney transplant failure after autologous transplantation of MSCs used as rescue treatment of late antibody-mediated kidney allograft rejection.<\/jats:p>","DOI":"10.3389\/fmed.2021.708744","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T09:32:13Z","timestamp":1626859933000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem Cell Therapy"],"prefix":"10.3389","volume":"8","author":[{"given":"\u017deljka","family":"Ve\u010deri\u0107-Haler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nika","family":"Kojc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matja\u017e","family":"Sever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samo","family":"Zver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urban","family":"\u0160vajger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Primo\u017e","family":"Po\u017eenel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Urdih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Mlin\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manca","family":"Oblak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreja","family":"Ale\u0161 Rigler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alojz","family":"Ihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadranka","family":"Buturovi\u0107 Ponikvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip P.","family":"Halloran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miha","family":"Arnol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","article-title":"Mesenchymal stem cell perspective: cell biology to clinical progress","volume":"4","author":"Pittenger","year":"2019","journal-title":"NPJ Regen Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2215\/CJN.04950610","article-title":"Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility","volume":"6","author":"Perico","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1001\/jama.2012.316","article-title":"Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial","volume":"307","author":"Tan","year":"2012","journal-title":"JAMA."},{"key":"B4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/tri.12132","article-title":"Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation","volume":"26","author":"Perico","year":"2013","journal-title":"Transpl Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5966\/sctm.2012-0114","article-title":"Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study","volume":"2","author":"Reinders","year":"2013","journal-title":"Stem Cells Transl Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/TP.0b013e3182754c53","article-title":"Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study","volume":"95","author":"Peng","year":"2013","journal-title":"Transplantation."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3109\/0886022X.2014.950931","article-title":"Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation - single center experience","volume":"36","author":"Vanikar","year":"2014","journal-title":"Ren Fail."},{"key":"B8","doi-asserted-by":"publisher","first-page":"12089","DOI":"10.18632\/oncotarget.7725","article-title":"Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study","volume":"7","author":"Pan","year":"2016","journal-title":"Oncotarget."},{"key":"B9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12967-018-1422-x","article-title":"Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial","volume":"16","author":"Sun","year":"2018","journal-title":"J Transl Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.kint.2018.08.046","article-title":"Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study","volume":"95","author":"Erpicum","year":"2019","journal-title":"Kidney Int."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16528.","article-title":"Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: the randomized prospective, single-center, open-label TRITON study","author":"Reinders","year":"2021","journal-title":"Am J Transplant."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1111\/ajt.14329","article-title":"Real time central assessment of kidney transplant indication biopsies by microarrays: the INTERCOMEX Study","volume":"17","author":"Halloran","year":"2017","journal-title":"Am J Transplant."},{"key":"B13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/ncpneph0609","article-title":"Parvovirus-B19-associated complications in renal transplant recipients","volume":"3","author":"Waldman","year":"2007","journal-title":"Nat Clin Pract Nephrol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1086\/504812","article-title":"Parvovirus B19 infection after transplantation: a review of 98 cases","volume":"43","author":"Eid","year":"2006","journal-title":"Clin Infect Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.bbmt.2008.08.003","article-title":"Persistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen: implications for transplantation","volume":"14","author":"Sundin","year":"2008","journal-title":"Biol Blood Marrow Transplant."},{"key":"B16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.kint.2016.11.029","article-title":"Capillary leak syndrome: etiologies, pathophysiology, and management","volume":"92","author":"Siddall","year":"2017","journal-title":"Kidney Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/j.bbmt.2015.08.030","article-title":"Engraftment syndrome after autologous stem cell transplantation: an update unifying the definition and management approach","volume":"21","author":"Cornell","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/bmt.2014.296","article-title":"Engraftment syndrome: double-edged sword of hematopoietic cell transplants","volume":"50","author":"Spitzer","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.1097\/MPH.0000000000001795","article-title":"Hemophagocytic lymphohistiocytosis and graft failure following unrelated umbilical cord blood transplantation in children","volume":"42","author":"Noguchi","year":"2020","journal-title":"J Pediatr Hematol Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/bmt.2014.169","article-title":"Autologous GVHD?","volume":"49","author":"Otegbeye","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"B21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.trim.2013.08.004","article-title":"Isogeneic MSC application in a rat model of acute renal allograft rejection modulates immune response but does not prolong allograft survival","volume":"29","author":"Koch","year":"2013","journal-title":"Transpl Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrneph.2016.7","article-title":"Mesenchymal stromal cells in renal transplantation: opportunities and challenges","volume":"12","author":"Casiraghi","year":"2016","journal-title":"Nat Rev Nephrol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fimmu.2012.00202","article-title":"Detrimental effects of rat mesenchymal stromal cell pre-treatment in a model of acute kidney rejection","volume":"3","author":"Seifert","year":"2012","journal-title":"Front Immunol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.708744\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T09:32:16Z","timestamp":1626859936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.708744\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":23,"alternative-id":["10.3389\/fmed.2021.708744"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.708744","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]},"article-number":"708744"}}